SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-217451
Filing Date
2022-08-10
Accepted
2022-08-10 16:58:57
Documents
14
Period of Report
2022-08-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d396834d8k.htm   iXBRL 8-K 28054
2 EX-5.1 d396834dex51.htm EX-5.1 12997
6 GRAPHIC g396834sp5.jpg GRAPHIC 2825
  Complete submission text file 0001193125-22-217451.txt   175645

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbtx-20220810.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbtx-20220810_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbtx-20220810_pre.xml EX-101.PRE 11713
8 EXTRACTED XBRL INSTANCE DOCUMENT d396834d8k_htm.xml XML 3471
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

IRS No.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40030 | Film No.: 221152523
SIC: 2834 Pharmaceutical Preparations